原发灶不明头颈鳞癌:累及颈侧放疗对比黏膜放疗
结果显示两组原发灶出现率和5年总生存无显著差异,INO组需长期肠内喂养的比例显著更低。
要点
- INO组与MUC组5年总生存分别为80%和82%,差异无统计学意义。
- INO组原发灶出现率2.7%,MUC组0.8%,差异无统计学意义。
- 放疗后≥12个月需肠内喂养者MUC组5.7%,INO组0%,差异有统计学意义。
核心结论
- 对于单侧原发灶不明头颈鳞癌,仅累及颈侧放疗的原发灶出现率低、毒性更低且总生存与黏膜放疗无差异,可能为当代实践中的可行选择。
主要发现
- INO组死于原发灶不明头颈鳞癌者17.8%,MUC组5.7%;MUC组死于非原发灶不明头颈鳞癌原因者15.6%,INO组4.1%。
临床怎么用
- 在FDG PET-CT排除原发灶后,对单侧原发灶不明头颈鳞癌可考虑仅照射累及颈侧以降低长期肠内喂养需求,同时需权衡原发灶出现与疾病特异性死亡风险。
局限性
- 本研究为回顾性观察性设计,原文未报告随机化或倾向性评分匹配等控制混杂的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Target volumes for irradiation remain ill-defined for head and neck squamous cell cancer of unknown primary (HNSCCUP). The aim of this study was to compare 2 commonly used radiation therapy strategies for patients diagnosed with HNSCCUP: ipsilateral or involved neck only (INO) versus bilateral neck and/or mucosal (MUC) radiation therapy, evaluating disease-related outcomes and enteral feeding rates. METHODS AND MATERIALS: This was a retrospective, observational, multicenter cohort study. Patients diagnosed with unilateral HNSCCUP between 2015 and 2023 who underwent radical (chemo) radiation therapy were eligible for analysis. All patients underwent 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography - Computed Tomography (PET-CT). HNSCCUP was a diagnosis of exclusion made on the basis of negative investigations to detect a primary site. Patient and tumor characteristics, treatment details, toxicities, and disease control were recorded and compared between the 2 radiation therapy strategies. RESULTS: One hundred ninety-five patients were eligible for analysis, 66% had human papillomavirus-associated disease. Seventy-three patients received INO (37%) and 122 patients received MUC radiation therapy (63%). The median duration of follow-up was 58 months (IQR, 42-72 months). The rate of primary site emergence was 2.7% in the INO and 0.8% in the MUC cohorts, P = .56. Five-year overall survival was 80% (95% CI, 70%-90%) for INO and 82% (95% CI, 75%-90%) for MUC radiation therapy, P = .74. Those undergoing INO radiation therapy were more likely to die from HNSCCUP (17.8% vs 5.7%), and those receiving MUC were more likely to die from a non-HNSCCUP cause (15.6% vs 4.1%). The need for enteral feeding ≥12 months from radiation therapy was 5.7% for MUC versus 0% for INO (P = .046). CONCLUSIONS: This is the largest series to date of patients with unilateral HNSCCUP treated radically with radiation therapy in the human papillomavirus and FDG PET-CT era. Acceptably low rates of primary site emergence, lower toxicity, and no difference in overall survival when compared with prophylactic MUC radiation therapy suggest that INO radiation therapy in HNSCCUP may be a feasible alternative in contemporary practice.
引用
- Peters AL, Poon WY, Walters S, et al. Involved Neck Only Versus Mucosal Radiation Therapy for Head and Neck Squamous Cell Cancer of Unknown Primary (HNSCCUP): A National Retrospective Multicenter Cohort Study. Int J Radiat Oncol Biol Phys. 2025. PMID: 41253268. doi:10.1016/j.ijrobp.2025.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。